Pemetrexed alone or in combination with cisplatin in previously treated patients with malignant pleural mesothelioma (MPM): Outcomes of an expanded access program (EAP).

被引：0
|
作者：
Orlando, M
Wozniak, A
Janne, P
Belani, CP
Keohan, ML
Ross, H
Polikoff, J
Mintzer, D
Bloss, L
Obasaju, C
机构：
[1] Lilly Res Labs, Indianapolis, IN USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Columbia Presbyterian Med Ctr, New York, NY 10032 USA
[5] Oregon Hlth Sci Univ, Portland, OR 97201 USA
[6] Kaiser Hosp San Diego, San Diego, CA USA
[7] Penn Hosp, Philadelphia, PA 19107 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7195
引用
收藏
页码：664S / 664S
页数：1
相关论文
共 50 条
  • [1] Survival update of a subset of previously treated patients with malignant pleural mesothelioma (MPM) in an expanded access program (eap) of pemetrexed (P) alone or combined with cisplatin (cis).
    Orlando, M
    Wozniak, TF
    Janne, PA
    Belani, CP
    Keohan, ML
    Ross, HJ
    Polikoff, J
    Mintzer, DM
    Ye, Z
    Obasaju, CK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 663S - 663S
  • [2] Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma:: Outcomes from a phase IIIB expanded access program
    Jaenne, Pasi A.
    Wozniak, Antoinette J.
    Belani, Chandra P.
    Keohan, Mary-Louise
    Ross, Helen J.
    Polikoff, Jonathan A.
    Mintzer, David M.
    Ye, Zhishen
    Monberg, Matthew J.
    Obasaju, Coleman K.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (06) : 506 - 512
  • [3] Open-label study of pemetrexed alone or in combination with a platinum for previously treated patients (pts) with malignant pleural mesothelioma (MPM): Outcomes from the International Expanded Access Program (EAP)
    Gatzemeier, Ulrich
    Taylor, Paul
    von Pawel, Joachim
    Castagneto, Bruno
    Dark, Graham
    Marangolo, Maurizio
    Van Klaveren, Rob J.
    Van Meerbeeck, Jan
    Adachi, Jan
    Blatter, Johannes
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S372 - S373
  • [4] Pemetrexed alone or in combination with cisplatin in the treatment of patients with peritoneal mesothelioma (PM): Outcomes of an expanded access program (EAP) in patients with malignant mesothelioma (MM).
    Bloss, J
    Wozniak, A
    Janne, P
    Belani, C
    Keohan, M
    Ross, H
    Polikoff, J
    Mintzer, D
    Bloss, L
    Obasaju, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 665S - 665S
  • [5] Pemetrexed (P) alone or in combination with platinum for malignant pleural mesothelioma (MPM): Efficacy and toxicity of the International Expanded Access Program (EAP) in Spanish patients (p)
    Moran, T.
    Gonzalez-Larriba, J.
    Montesinos, J.
    Delgado, J.
    Massuti, B.
    Lopez-Vivanco, G.
    Lopez-Picazo, J.
    Peiro, A.
    Paz-Ares, L. G.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Open-label study of pemetrexed alone or in combination with a platinum in chemonaive patients (pts) with malignant pleural mesothelioma (MPM): Results from the International Expanded Access Program (EAP)
    Manegold, Christian
    Santoro, Armando
    O'Brien, Mary E. r.
    Stahel, Rolf A.
    Nackaerts, Kristiaan
    Bass, Paul
    Paz-Ares, Luis
    Sundstrom, Stein
    Visseren-Grul, Carla
    Blatter, Johannes
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S371 - S371
  • [7] Open-label study of pemetrexed alone for chemonaive patients and pre-treated patients with malignant pleural mesothelioma: Outcomes of the International Expanded Access Program (EAP)
    Taylor, P.
    von Pawel, J.
    Castagneto, B.
    Dark, G.
    Marangolo, M.
    van Klaveren, R.
    van Meerbeeck, J.
    Adachi, S.
    Blatter, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Peinetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma:: outcomes from a phase IIIB expanded access program (vol 1, pg 506, 2006)
    Jaenne, P. A.
    Wozniak, A. J.
    Belani, C. P.
    Keohan, M-L
    Ross, H. J.
    Polikoff, J. A.
    Mintzer, D. M.
    Ye, Z.
    Monberg, M. J.
    Obasaju, C. K.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (07) : 621 - 621
  • [9] Pemetrexed plus cisplatin (P plus Cis) or pemetrexed plus carboplatin (P plus Cb) for chemonaive patients (pts) with malignant pleural mesothelioma (MPM): Results of the International Expanded Access Program (EAP)
    Santoro, A.
    O'Brien, M.
    Stahel, R.
    Nackaerts, K.
    Baas, P.
    Paz-Ares, L.
    Sundstrom, S.
    Visseren-Grul, C.
    Blatter, J.
    Manegold, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Pemetrexed plus cisplatin (P plus CIS) or carboplatin (P plus CB) in chemonaive malignant pleural mesothelioma (MPM) patients (PTS): Results of the international expanded access program (EAP)
    Santoro, A.
    Zucali, P. A.
    O'Brien, M.
    Stahel, R.
    Nackaerts, K.
    Baas, P.
    Paz-Ares, L.
    Sundstrom, S.
    Blatter, J.
    Manegold, C.
    ANNALS OF ONCOLOGY, 2007, 18 : 32 - 32
12345